GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Intelligent Medicine Acquisition Corp (NAS:IQMDU) » Definitions » Ending Cash Position

IQMDU (Intelligent Medicine Acquisition) Ending Cash Position : $0.05 Mil (As of Dec. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Intelligent Medicine Acquisition Ending Cash Position?

Intelligent Medicine Acquisition's Ending Cash Position for the quarter that ended in Dec. 2022 was $0.05 Mil.

Intelligent Medicine Acquisition's quarterly Ending Cash Position declined from Jun. 2022 ($0.26 Mil) to Sep. 2022 ($0.16 Mil) and declined from Sep. 2022 ($0.16 Mil) to Dec. 2022 ($0.05 Mil).

Intelligent Medicine Acquisition's annual Ending Cash Position stayed the same from . 20 ($0.00 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.05 Mil).


Intelligent Medicine Acquisition Ending Cash Position Historical Data

The historical data trend for Intelligent Medicine Acquisition's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Medicine Acquisition Ending Cash Position Chart

Intelligent Medicine Acquisition Annual Data
Trend Dec21 Dec22
Ending Cash Position
- 0.05

Intelligent Medicine Acquisition Quarterly Data
Feb21 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22
Ending Cash Position Get a 7-Day Free Trial - - 0.26 0.16 0.05

Intelligent Medicine Acquisition Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Intelligent Medicine Acquisition's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.589+-0.539
=0.05

Intelligent Medicine Acquisition's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.502+-0.452
=0.05


Intelligent Medicine Acquisition Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Intelligent Medicine Acquisition's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Medicine Acquisition Business Description

Traded in Other Exchanges
N/A
Address
9001 Burdette Road, Bethesda, MD, USA, 20817
Intelligent Medicine Acquisition Corp is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Executives
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Saba Capital Management, L.p. 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Boaz Weinstein 10 percent owner 405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Joseph L Schocken director 2800 UNION SQUARE, 600 UNIVERSITY STREET, SEATTLE WA 98101
Kavita Patel director C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451
Jack Hidary director 3 PARK AVENUE, NEW YORK NY 10016
Gregory C Simon director, officer: CEO and CFO 9001 BURDETTE RD., BETHESDA MD 20817
Patience Marime-ball director 9001 BURDETTE RD., BETHESDA MD 20817
Intelligent Medicine Sponsor Llc 10 percent owner 9001 BURDETTE ROAD, BETHESDA MD 20817